CSIMarket
 


Neurocrine Biosciences Inc   (NBIX)
Other Ticker:  
 


Neurocrine Biosciences Inc 's Effective Tax Rate by quarter

Trends, Rankings, Statistics



NBIX Effective Tax Rate (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Pre-Tax Income Change 68.11 % 18.08 % - - 59.76 %
Seq. Pre-Tax Income Change 71.45 % -4.93 % - - 20.43 %
Pre-Tax Income In Millions $198.20 $115.60 $121.60 $-103.30 $117.90
Effective Tax Rate 25.48 % 28.11 % 21.46 % - 24.51 %
Effective Tax Rate Total Ranking # 1000 # 1699 # 907 # # 1515
Income taxes expenses / -benefit In Millions $50.50 $32.50 $26.10 $-26.70 $28.90
Y / Y Income taxes expenses / -benefit Change 74.74 % 10.54 % - - 2790 %
Seq. Income taxes expenses / -benefit Change 55.38 % 24.52 % - - -1.7 %


Commenting fourth Quarter 2023 Effective Tax Rate
Company's effective tax rate in IV. Quarter decreased compare to previous quarter to 25.48 %, above company's average Effective Tax Rate.

Looking into IV. Quarter results within Biotechnology & Pharmaceuticals industry 11 other companies have achieved lower Effective Tax Rate. While Effective Tax Rate total ranking has impoved so far to 1000, from total ranking in previous quarter at 1699.

NBIX's Effective Tax Rate fourth quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 12
Healthcare Sector # 72
Overall # 999

NBIX's Effective Tax Rate Statistics
High Average Low
35.05 % 16.09 % 1.36 %
(Mar 31 2022)   (Dec 31 2021)




Other Effective Tax Rate Profitability Ratios
NBIX's Cumulative Effective Tax Rate
Biotechnology & Pharmaceuticals Industry Effective Tax Rate Trends and Statistics
Healthcare Sector Effective Tax Rate Statistics
Effective Tax Rate Profitability Trends for overall market
NBIX's Effective Tax Rate Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Effective Tax Rate
Lowest Ranking Effective Tax Rate
Effective Tax Rate Profit Margin for NBIX's Competitors
Effective Tax Rate Profit Margin for Neurocrine Biosciences Inc 's Suppliers
Effective Tax Rate Profit Margin for NBIX's Customers

You may also want to know
NBIX's Annual Growth Rates NBIX's Profitability Ratios NBIX's Asset Turnover Ratio NBIX's Dividend Growth
NBIX's Roe NBIX's Valuation Ratios NBIX's Financial Strength Ratios NBIX's Income taxes expenses / -benefit Growth
NBIX's Roa NBIX's Inventory Turnover Ratio NBIX's Growth Rates NBIX's Dividend Comparisons


Companies with similar Effective Tax Rate in the quarter ending Dec 31 2023, within Biotechnology & Pharmaceuticals Industry Effective Tax RateDec 31 2023 MRQ Income taxes expenses / -benefitDec 31 2023 MRQ Pre-Tax Income
Neurocrine Biosciences Inc   25.48 %$ 50.500 $ 198.200 
Biontech Se  21.57 %$ 286.496 $ 1,328.432 
Qiagen N v   20.59 %$ 88.506 $ 429.809 
Krystal Biotech Inc   18.44 %$ 1.965 $ 10.657 
Bio techne Corp  17.74 %$ 5.922 $ 33.387 
Halozyme Therapeutics Inc   15.60 %$ 15.787 $ 101.175 
Biogen Inc   14.64 %$ 42.700 $ 291.600 
Gilead Sciences Inc   14.28 %$ 236.000 $ 1,653.000 
Amgen Inc   9.98 %$ 85.000 $ 852.000 
Exelixis Inc   8.50 %$ 17.521 $ 206.078 
Vericel Corporation  7.81 %$ 1.100 $ 14.093 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com